21/12/2018

Giovannelli e Associati advised Altheia Science on a capital increase of its corporate capital

Giovannelli e Associati advised Altheia Science, a biotech start-up incorporated to develop curative medicine for autoimmune diseases (multiple sclerosis and diabetes) on the capital increase of […]
21/12/2018

Giovannelli e Associati has advised H-Farm

Giovannelli e Associati has advised H-Farm, venture capital incubator listed in the AIM Italia stock market, in the preparatory activity aimed to the investment in Diana […]
21/12/2018

Giovannelli e Associati with Rubinetterie Cristina for the Patent Box tax benefit

Giovannelli e Associati advised Rubinetterie Cristina (part of Caleffi Group), an international leader in the production of manufacturing bathroom fitting and fixtures, on the administrative procedure […]
28/11/2018

Giovannelli e Associati advised Ardian on the acquisition of a majority stake of Neopharmed Gentili Group

Giovannelli e Associati advised the French private equity fund Ardian on the acquisition of a majority stake of Neopharmerd Gentili group, a pharmaceutical company, from Mediolanum […]